Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Testosterone Cypionate Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Testosterone Cypionate Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 200 mg/mL
      • 1.3.3 100 mg/mL
    • 1.4 Market Segment by Application
      • 1.4.1 Global Testosterone Cypionate Market Share by Application (2019-2025)
      • 1.4.2 Primary hypogonadism
      • 1.4.3 Hypogonadotropic hypogonadism
      • 1.4.4 Late-onset hypogonadism
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Testosterone Cypionate Market Size
      • 2.1.1 Global Testosterone Cypionate Revenue 2014-2025
      • 2.1.2 Global Testosterone Cypionate Sales 2014-2025
    • 2.2 Testosterone Cypionate Growth Rate by Regions
      • 2.2.1 Global Testosterone Cypionate Sales by Regions 2014-2019
      • 2.2.2 Global Testosterone Cypionate Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Testosterone Cypionate Sales by Manufacturers
      • 3.1.1 Testosterone Cypionate Sales by Manufacturers 2014-2019
      • 3.1.2 Testosterone Cypionate Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Testosterone Cypionate Revenue by Manufacturers (2014-2019)
      • 3.2.2 Testosterone Cypionate Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Testosterone Cypionate Market Concentration Ratio (CR5 and HHI)
    • 3.3 Testosterone Cypionate Price by Manufacturers
    • 3.4 Key Manufacturers Testosterone Cypionate Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Testosterone Cypionate Market
    • 3.6 Key Manufacturers Testosterone Cypionate Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 200 mg/mL Sales and Revenue (2014-2019)
      • 4.1.2 100 mg/mL Sales and Revenue (2014-2019)
    • 4.2 Global Testosterone Cypionate Sales Market Share by Type
    • 4.3 Global Testosterone Cypionate Revenue Market Share by Type
    • 4.4 Testosterone Cypionate Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Testosterone Cypionate Sales by Application

    6 United States

    • 6.1 United States Testosterone Cypionate Breakdown Data by Company
    • 6.2 United States Testosterone Cypionate Breakdown Data by Type
    • 6.3 United States Testosterone Cypionate Breakdown Data by Application

    7 European Union

    • 7.1 European Union Testosterone Cypionate Breakdown Data by Company
    • 7.2 European Union Testosterone Cypionate Breakdown Data by Type
    • 7.3 European Union Testosterone Cypionate Breakdown Data by Application

    8 China

    • 8.1 China Testosterone Cypionate Breakdown Data by Company
    • 8.2 China Testosterone Cypionate Breakdown Data by Type
    • 8.3 China Testosterone Cypionate Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Testosterone Cypionate Breakdown Data by Company
    • 9.2 Rest of World Testosterone Cypionate Breakdown Data by Type
    • 9.3 Rest of World Testosterone Cypionate Breakdown Data by Application
    • 9.4 Rest of World Testosterone Cypionate Breakdown Data by Countries
      • 9.4.1 Rest of World Testosterone Cypionate Sales by Countries
      • 9.4.2 Rest of World Testosterone Cypionate Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Pfizer
      • 10.1.1 Pfizer Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Testosterone Cypionate
      • 10.1.4 Testosterone Cypionate Product Introduction
      • 10.1.5 Pfizer Recent Development
    • 10.2 Cipla
      • 10.2.1 Cipla Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Testosterone Cypionate
      • 10.2.4 Testosterone Cypionate Product Introduction
      • 10.2.5 Cipla Recent Development
    • 10.3 Sun Pharmaceutical
      • 10.3.1 Sun Pharmaceutical Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Testosterone Cypionate
      • 10.3.4 Testosterone Cypionate Product Introduction
      • 10.3.5 Sun Pharmaceutical Recent Development
    • 10.4 Teva
      • 10.4.1 Teva Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Testosterone Cypionate
      • 10.4.4 Testosterone Cypionate Product Introduction
      • 10.4.5 Teva Recent Development
    • 10.5 Perrigo
      • 10.5.1 Perrigo Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Testosterone Cypionate
      • 10.5.4 Testosterone Cypionate Product Introduction
      • 10.5.5 Perrigo Recent Development
    • 10.6 Hikma Pharmaceuticals
      • 10.6.1 Hikma Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Testosterone Cypionate
      • 10.6.4 Testosterone Cypionate Product Introduction
      • 10.6.5 Hikma Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Testosterone Cypionate Sales Channels
      • 11.2.2 Testosterone Cypionate Distributors
    • 11.3 Testosterone Cypionate Customers

    12 Market Forecast

    • 12.1 Global Testosterone Cypionate Sales and Revenue Forecast 2019-2025
    • 12.2 Global Testosterone Cypionate Sales Forecast by Type
    • 12.3 Global Testosterone Cypionate Sales Forecast by Application
    • 12.4 Testosterone Cypionate Forecast by Regions
      • 12.4.1 Global Testosterone Cypionate Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Testosterone Cypionate Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men. It is also used in hormone therapy for transgender men. It is given by injection into muscle or subcutaneously, once every one to four weeks, depending on clinical indication.
      In 2019, the market size of Testosterone Cypionate is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Testosterone Cypionate.

      This report studies the global market size of Testosterone Cypionate, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Testosterone Cypionate sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Pfizer
      Cipla
      Sun Pharmaceutical
      Teva
      Perrigo
      Hikma Pharmaceuticals
      ...

      Market Segment by Product Type
      200 mg/mL
      100 mg/mL

      Market Segment by Application
      Primary hypogonadism
      Hypogonadotropic hypogonadism
      Late-onset hypogonadism

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Testosterone Cypionate status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Testosterone Cypionate manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Testosterone Cypionate are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now